Unknown

Dataset Information

0

[CMP] [cell line] [SIDM00096] Anaplastic Large Cell Lymphoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO1825 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Ceritinib in patients with advanced anaplastic lymphoma kinase-rearranged anaplastic large-cell lymphoma.
| S-EPMC4559938 | biostudies-literature
Unknown Blood cytokine concentrations in pediatric patients with anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
| S-EPMC5830391 | biostudies-literature
Unknown Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma.
| S-EPMC8271116 | biostudies-literature
Unknown Anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma with primary bone involvement: a case report.
| S-EPMC10789887 | biostudies-literature
Unknown Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma.
| S-EPMC3299366 | biostudies-literature
Unknown ALK-positive anaplastic large cell lymphoma in adults.
| S-EPMC10467138 | biostudies-literature
Unknown From Pathology to Precision Medicine in Anaplastic Large Cell Lymphoma Expressing Anaplastic Lymphoma Kinase (ALK+ ALCL).
| S-EPMC5664077 | biostudies-literature
Unknown Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.
| S-EPMC10232850 | biostudies-literature
Unknown Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma.
| S-EPMC5912135 | biostudies-literature
Unknown B7-H3 Chimeric Antigen Receptor Redirected T Cells Target Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma.
| S-EPMC7766167 | biostudies-literature